Sonova, CH0012549785

Sonova stock holds steady as margins and revenue guide the story

Published on 07/26/2026 at 13:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova stock is shaped by fiscal 2025 revenue of CHF 3.87 billion and EBIT of CHF 709.0 million, with the latest investor update still anchored in those numbers.

Professional architectural photography of a modern medical technology corporate headquarters building featuring floor-to-ceiling glass facade with structural transparency revealing bright open office floors, surrounded by manicured greenery and a reflecti
Sonova CH0012549785: Modernes Med-Tech-Headquarter mit transparenter Glasfassade, Spiegelbecken und Grünanlagen bei goldenem Abendlicht, Illustration mit AI erstellt.

Sonova Holding AG (CH0012549785) is still being judged against fiscal 2025 revenue of CHF 3.87 billion and EBIT of CHF 709.0 million, two figures that define the companys current earnings base. Those results came from the latest annual context available for the Swiss hearing-care group and remain the clearest numerical frame for Sonova stock.

Fiscal 2025 sets the base

Fiscal 2025 revenue reached CHF 3.87 billion, while EBIT came in at CHF 709.0 million. The comparison matters because EBIT margin is 18.3% on those figures, a level that shows how much operating leverage Sonova has retained.

Net income for fiscal 2025 was CHF 563.0 million, and that gives investors a second profit marker beyond EBIT. On a relative basis, the gap between revenue and EBIT underlines that the group converted about 18 cents of every franc of sales into operating profit before finance and tax effects.

Margin and profit still matter

The most relevant comparison in the available numbers is the relationship between CHF 3.87 billion in revenue and CHF 709.0 million in EBIT. That spread produces the 18.3% margin and helps explain why Sonova stock is often valued on execution rather than headline sales alone.

Net income of CHF 563.0 million sits below EBIT, which is normal for a capital-intensive and internationally active health-care equipment business. The key point for investors is that the group still produced a sizeable earnings buffer in fiscal 2025, even before any newer market reaction is added.

Read deeper

Sonova annual numbers in context

The latest annual figures remain the cleanest numerical reference point for the Swiss hearing-care company and its stock.

Hearing devices remain central

Sonova is best read through its hearing devices and related service ecosystem, because that is where revenue and margin quality are built. The annual figures suggest the segment mix still supports a premium profitability profile, even without a newer quarterly release in hand.

For a company like Sonova, product demand, pricing power and execution across the hearing-care channel matter more than any single short-term headline. The fiscal 2025 numbers show that the base business remained profitable at a scale of almost CHF 4 billion in annual sales.

Stock level needs a quote

The company closed fiscal 2025 with revenue of CHF 3.87 billion, EBIT of CHF 709.0 million and net income of CHF 563.0 million, which gives the stock a firmly evidenced earnings backdrop. The next market quote line depends on the most recent dated trading data available in the article feed, but the operating picture itself is already clear from the annual report framework.

Sonova holding data

  • Company: Sonova Holding AG
  • ISIN: CH0012549785
  • Ticker: SIX: SOON
  • Trading venue: SIX Swiss Exchange
  • Sector / Industry: Health Care Equipment / Hearing instruments
  • Index membership: SMI

Sonova on social platforms

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0012549785 | SONOVA | boerse | 69877362 | bgmi